Month: November 2021

Medicare open enrollment for 2022 ends on December 7th. No doubt, like me, you have seen the countless commercials and even 30-minute-long infomercials from various Medicare Advantage plans touting the great benefits of these plans—like dental and vision coverage, gym memberships, meals, transportation to medical appointments—and many others. For some, Medicare Advantage plans are good
0 Comments
Why do so many people regularly wake up at obscure times of the morning? This study might have the answer It’s a scenario many of us will be familiar with. You roll over, suddenly wide awake, check the time, and it’s 4.44 AM – or thereabouts. So what’s the deal with waking up at that
0 Comments
With COP26 underway, buying second-hand clothes is one way you can contribute to the fight against climate change.  Fashion influencer, Shannon Alexandra, at the Love Not Landfill pop-up shop in Angel. Cancer Research UK has presented a clothing collection in collaboration with influencer Shannon Alexandra at the return of Love Not Landfill’s London charity fashion
0 Comments
Regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with docetaxel, according to research presented at the NCRI Festival. The findings could enable doctors to detect early on, without invasive procedures, if a treatment is working and switch to alternatives
0 Comments
Follow these eight practical tips for embracing and building self-love The road to self-love is rarely straightforward. It includes twists, turns, hurdles, and challenges – and, above all, it’s going to take time. We have a good idea of what it means to love another person – you care about their wellbeing, you root for
0 Comments
Hepatic arterial infusion chemotherapy (HAIC) with FOLFOX led to superior patient outcomes and less toxicity than standard of care transarterial chemoembolization (TACE) for patients with large, unresectable hepatocellular carcinoma (HCC), a randomized, phase 3 trial has shown. In a group of 315 patients with unresectable tumors at least 7 cm in diameter and no macrovascular
0 Comments
A vial of Pfizer-BioNTech Covid-19 vaccine is seen at a pop up vaccine clinic in the Arleta neighborhood of Los Angeles, California, August 23, 2021. Robyn Beck | AFP | Getty Images A pharmacy in Virginia incorrectly administered Pfizer and BioNTech’s Covid-19 shots to 112 children last week, according to the state Department of Health.
0 Comments
Few rheumatoid arthritis patients whose initial experience with tumor necrosis factor (TNF) inhibitors was suboptimal achieved “low disease activity” status upon switching to another biologic, whether it was another TNF inhibitor or another class of drug, researchers found. Analysis of 939 patients in the registry database formerly known as Corrona (renamed CorEvitas earlier this year)
0 Comments
NEW ORLEANS — Everyone who received their second dose of the Moderna or Pfizer mRNA vaccine against COVID-19 at military facilities after experiencing allergic reactions to the first did just fine without any pretreatment, a physician reported here. These individuals were observed closely, of course, and some underwent allergy testing beforehand to ascertain whether they
0 Comments
With one in five Brits admitting to sugar being their biggest vice, how much do we really know about our sugar consumption? Sugar. We all know it’s not exactly good for us, but do any of us realise the impact it can have on our health, physically and mentally? And do we really know how
0 Comments
Lung cancer cells under a microscope. Credit: LRI EM Unit 3 new cancer drugs have been given the go-ahead by the Scottish Medicines Consortium (SMC) for routine use in Scotland, but a fourth has been rejected. The approved drugs are: Atezolizumab (Tecentriq) for adults with non small cell lung cancer that has spread to another
0 Comments
Vanessa Dietzel, author of The Performance Curve, explains the effect purpose can have on our wellbeing, and how we can harness this power for our own good From a really young age, my twin brother had a clear sense of his purpose in crafting unique experiences through technology such as lasers. Pursuing this purpose brought
0 Comments
Studies have shown that mortality rates in hospitalized patients with COVID-19 are high, ranging between 10% and 30%. REGEN-COV®, a combination of monoclonal antibodies casirivimab and imdevimab, is approved in the United States and other regions for emergency treatment of COVID-19 outpatients with mild to moderate SARS-CoV-2 infection and post-exposure prophylaxis. REGEN-COV has been shown
0 Comments
A novel noninvasive endoscopy trial lends further support for the safety of single antiplatelet therapy after a 6-month course of dual antiplatelet therapy (DAPT) in patients undergoing percutaneous coronary intervention (PCI). Results from the OPT-PEACE trial show that patients at low bleeding risk on aspirin or clopidogrel monotherapy for an additional 6 months after DAPT
0 Comments
Dr. Christopher Boes, a neurologist and Division Chair of Neurology Education at Mayo Clinic, discusses new drugs to help prevent migraine headaches. Dr. Boes is also a content editor for the Mayo Clinic Health Letter. To learn more about migraine headaches, visit: https://www.mayoclinic.org/diseases-conditions/migraine-headache/symptoms-causes/syc-20360201
0 Comments
Semi-trailer trucks move along Lincoln Highway while using the indirect interchange from Interstates 70, the Pennsylvania Turnpike and U.S. Route 30 on October 14, 2021 in Breezewood, Pennsylvania. Chip Somodevilla | Getty Images National industry groups representing retail, truckers and independent businesses sued the Biden administration on Wednesday over its vaccine and testing requirements for
0 Comments
NEW ORLEANS — Although still technically an orphan disease, hereditary angioedema (HAE) remains a popular focus for drug developers despite a half-dozen products already approved in the U.S. That was on full display at the American College of Allergy, Asthma and Immunology’s annual meeting here, with phase II studies on two investigational agents featured in
0 Comments